MECOM and acute myeloid leukemia: Consistently, MG132 treatment partially rescues the EVI1 level in 3q26 AML cell lines (Fig. 6H and Supplementary Fig. 10D), suggesting that PA2G4 acts as a scaffolding protein for EVI1 transcriptional complex.